Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerSteven D. Leach, John A. Moral, Romain Remark et al.|Nature|2017Cited by 1.2k
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Vinod P. Balachandran, Abderezak Zebboudj et al.|Nature|2025Cited by 83
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Mary E. Duffy et al.|Nature Cancer|2023Cited by 27